Back

Results - Announcements

Sales decline 9.05% to Rs 135.41 crore

Syncom Formulations (India) consolidated net profit rises 42.28% in the March 2026 quarter

23-May-2026, 07:21
Net profit of Syncom Formulations (India) rose 42.28% to Rs 25.17 crore in the quarter ended March 2026 as against Rs 17.69 crore during the previous quarter ended March 2025. Sales declined 9.05% to Rs 135.41 crore in the quarter ended March 2026 as against Rs 148.88 crore during the previous quarter ended March 2025.

For the full year,net profit rose 54.64% to Rs 76.44 crore in the year ended March 2026 as against Rs 49.43 crore during the previous year ended March 2025. Sales rose 5.20% to Rs 489.17 crore in the year ended March 2026 as against Rs 465.01 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	135.41	148.88	-9	489.17	465.01	5
OPM %	16.25	11.92	-	15.83	11.64	-
PBDT	36.18	24.58	47	107.61	70.70	52
PBT	33.70	23.29	45	101.08	65.50	54
NP	25.17	17.69	42	76.44	49.43	55